Latest News About Marty Makary

Here are the latest widely reported updates on Marty Makary, based on recent coverage:

• In 2025, Makary was nominated by President Donald Trump to lead the FDA and was widely discussed in Senate confirmation hearings. The discussions focused on his pandemic-era views and his potential approach to FDA leadership.[2][4]
• He was confirmed as FDA commissioner in March 2025 and began implementing reforms aimed at modernizing regulatory processes and exploring AI-assisted review tools, according to contemporaneous reporting. He later resigned in May 2026 after policy shifts related to e-cigarette regulation.[1][2]
• Public coverage around his tenure highlighted mixed assessments: some observers praised his policy expertise and surgical background, while others questioned the fit of his views with the regulatory and scientific rigor expected at the FDA.[2]

Key sources you can consult for deeper context:

• A profile/summary of his FDA tenure and resignation timeline: "Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA" (KFF Health News).[2]
• Articles detailing the confirmation process and the scope of his proposed reforms at the FDA: coverage from sources such as the Washington Times and other outlets from early 2025.[4][10]
• Public-facing materials on his career and positions: his personal site and public appearances, including interviews and talks around 2024–2026.[5][6]

Would you like me to pull the most up-to-date articles from specific outlets (e.g., major national newspapers or health policy outlets) and summarize any new developments since May 2026? If you have a preferred publication or a particular angle (e.g., regulatory reforms, AI in FDA reviews, drug pricing), tell me and I’ll tailor the roundup.

Citations:

• Makary FDA nomination and confirmation timeline.[2]
• Makary’s FDA tenure and resignation context.[1]
• Additional contemporaneous reporting on his nomination and reception.[10][4]